8-K: Catheter Precision Files Series C-4 Convertible Preferred Stock Designation

Catheter Precision, Inc. has filed a Certificate of Designation for its Series C-4 Convertible Preferred Stock, detailing its terms and rights.

Summary

• Catheter Precision, Inc. has filed a Certificate of Designation for its Series C-4 Convertible Preferred Stock.
• The Series C-4 Preferred Stock has a stated value of $1,000 per share and is convertible into Common Stock at a conversion price of $0.35 per share.
• Up to 80,000 shares of Series C-4 Preferred Stock can be issued.
• Holders are entitled to dividends when declared by the Board of Directors.
• In case of liquidation, holders receive the stated value plus accrued dividends before common stockholders.
• The stock has no voting rights except in specific circumstances requiring majority holder approval.
• The company has covenants restricting further indebtedness, liens, and certain corporate actions without holder consent.
• On July 30, 2026, the company closed the sale of 2,821 shares of Series C-4 Preferred Stock for $2,821,000 in gross proceeds.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it details a standard capital raise through convertible preferred stock, which provides necessary funding but also introduces potential future dilution for common shareholders.

Positives

• The filing clarifies the terms and rights associated with the Series C-4 Convertible Preferred Stock, providing transparency for investors.
• The conversion price of $0.35 per share offers a potential upside for investors if the common stock price increases.
• The company secured $2,821,000 in gross proceeds from the sale of Series C-4 Preferred Stock, which can be used for working capital and general corporate purposes.
• The stated value of $1,000 per share provides a liquidation preference over common stock.

Negatives

• The conversion of Series C-4 Preferred Stock into Common Stock will result in dilution for existing common stockholders.
• The terms of the Series C-4 Preferred Stock place restrictions on the company's ability to incur further indebtedness and liens without holder consent.
• The company cannot redeem, purchase, or acquire any Junior Securities while Series C-4 Preferred Stock is outstanding.
• The company cannot pay dividends or make distributions on Junior Securities while Series C-4 Preferred Stock is outstanding.

Risks

• Potential dilution to existing common stockholders upon conversion of Series C-4 Preferred Stock.
• Restrictions on the company's ability to incur additional debt or liens could limit future financing options.
• The company's ability to pursue certain strategic transactions may be constrained by the covenants associated with the Series C-4 Preferred Stock.
• The conversion price is subject to adjustments, which could impact the number of shares issued upon conversion.

Future Outlook

The Series C-4 Preferred Stock is convertible into Common Stock, subject to beneficial ownership limitations and market trading rules. The net proceeds are intended for working capital, general corporate purposes, and the redemption of Series B Convertible Preferred Stock. The company has covenants in place that restrict certain actions, such as incurring additional indebtedness or liens, without the consent of the holders of the Preferred Stock.

Industry Context

StockSavvy.ai notes that the issuance of convertible preferred stock is a common method for early-stage and growth companies to raise capital. However, it often comes with the trade-off of potential future dilution for existing common shareholders. The specific terms, including conversion price and protective covenants, are critical for assessing the impact on the company's financial flexibility and shareholder value.

Corporate Governance

Stakeholder Impact

• Common Stockholders: Potential dilution upon conversion of Series C-4 Preferred Stock.
• Series C-4 Preferred Stockholders: Entitled to specific rights, preferences, and conversion privileges as outlined in the Certificate of Designation.
• Series B Preferred Stockholders: Their stock is slated for redemption using proceeds from the Series C-4 issuance.
• Creditors: The covenants in the Certificate of Designation may restrict the company's ability to incur additional debt, potentially impacting future credit availability.

Next Steps

• Use net proceeds for working capital and general corporate purposes.
• Redeem all issued and outstanding Series B Convertible Preferred Stock.
• Holders of Series C-4 Preferred Stock may convert their shares into Common Stock under specified conditions.
• The company must adhere to covenants restricting further indebtedness and liens without holder consent.

Key Dates

Recommendation

The filing details a capital raise via convertible preferred stock, which provides necessary funding but also introduces potential dilution. The terms are standard for this type of instrument, and without further operational or financial performance data, a 'hold' recommendation is prudent, pending a clearer view of the company's growth trajectory and the impact of the new capital.

Keywords

Convertible Preferred Stock, Certificate of Designation, Series C-4, Capital Raise, Equity Financing, Shareholder Dilution, Corporate Governance, Securities Law